article thumbnail

Canopy Growth Corporation patented cannabis extraction infringed, CGC v. GWPH

Cannabis Life Network

Canopy Growth Corporation acquired a patented cannabis extraction technique that GW Pharmaceuticals allegedly infringed. Greenwich Biosciences is a US subsidiary of GW Pharmaceuticals […]. The post Canopy Growth Corporation patented cannabis extraction infringed, CGC v.

article thumbnail

Flora Growth Completes Successful First Cannabis Extraction Through New Facility, Initiates EU-GMP Certification Process

Cannabis Law Report

Flora’s cultivation and extraction division, Cosechemos, completed construction of a 10,500 ft 2 state-of-the-art post-harvest and extraction facility with annual capacity of 15,000 L of distillate. At this time, the team is continuing commercial CBD extraction.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

Devonian Health Group Announces Cannabis Cutting-Edge Extraction Equipment in Its Montmagny Facility

Cannabis Law Report

(“Devonian” or the “Corporation”) (TSXv:GSD), a clinical stage botanical pharmaceutical corporation, focused on developing a unique portfolio of botanical pharmaceutical and cosmeceutical products, announced today the signature of a lease Agreement with Hzb Pharma Canada Inc. Tweet this.

article thumbnail

Flora Growth Launches Cutting-Edge Global Cannabis Distribution Strategy, Implements Pharmaceutical Standards For Its Supply Chain

Cannabis Law Report

Flora will now have the ability to quickly and efficiently reference and manage information at its cultivation and extraction facility, collect and analyze data, derive insights to find cost efficiencies, and ensure accuracy. MIAMI & TORONTO–(BUSINESS WIRE)–Flora Growth Corp. For more information, please visit www.trutrace.co.

article thumbnail

Latin Investment Summit – Cannabis

Cannabis Law Report

We apply our entirely subjective bong score to each event. CannaVerde Pharma is a vertically integrated medical cannabis company with core operations in Colombia, focused on delivering low-cost, pharmaceutical grade, EU-GMP compliant cannabis-based products to consumers and medical patients in Latin America and Europe. BONG SCORE.

Sleep 105
article thumbnail

Curaleaf International Advances Accessibility of Medical Cannabis Products in Germany with Strategic Partnership

Cannabis Law Report

Pharmaceutical and Medical Cannabis Leaders Zambon GmbH and Adven GmbH will Drive Medical Cannabis Supporting Treatments for Neurological Therapies. Zambon is a multinational pharmaceutical company that focuses on innovation and development with the aim to improve patients’ lives. The market for medical cannabis in Germany.

Access 105
article thumbnail

Mydecine Expands Portfolio of Novel Molecules Filing New Patent for MDMA-like Compounds

Cannabis Law Report

With full government approval through Health Canada for exclusive access to a full cGMP-certified pharmaceutical manufacturing facility, Mydecine continues to advance the clinical progress in its 4 leading novel compounds, MYCO-001 through 004 with the ability to import or export, cultivate, extract or isolate, and analyze active mushroom compounds.